Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is acquiring commercial endocrinology biotech Crinetics Pharmaceuticals in a $10 billion deal.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Vertex Pharmaceuticals has reached an agreement to acquire Crinetics Pharmaceuticals for $10 billion. This acquisition marks the largest deal to date for Vertex.
Coverage from Bloomberg, The Wall Street Journal, and STAT emphasizes that the deal occurs amid a broader boom in biotech mergers and acquisitions. Following the announcement, Yahoo Finance reports that CRNX stock rose nearly 100% in after-hours trading.
Future developments will depend on the completion of the acquisition process as Vertex integrates the commercial endocrinology firm into its operations.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 9m ago.
Quick answers
How much is Vertex paying for Crinetics Pharmaceuticals?
The deal is valued at $10 billion.
How did the market react to the news?
According to Yahoo Finance, CRNX stock soared nearly 100% after-hours.
What is Crinetics Pharmaceuticals' area of specialization?
Crinetics is described as a commercial endocrinology biotech.
Coverage (5)
- Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms STAT · 10h ago
- Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet Bloomberg.com · 10h ago
- CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition Yahoo Finance · 10h ago
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion WSJ · 10h ago
- Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics Endpoints News · 10h ago broke it first
People, places & organizations
Topics
Related trends
Private prison company sells two of California’s immigrant detention centers to the feds
CoreCivic has sold two privately-owned immigrant detention centers in California to the federal government in a $1.5 billion deal.
Louis Vuitton logo dispute sparks cultural design debate
Tesla Robotaxi Expands To Miami As Slow Rollout Continues. Stock Ticks Up.
Tesla has expanded its Robotaxi service into a limited zone in Miami, sparking a slight increase in stock price.
Asian Stocks Set to Gain After Tech-Powered Rally: Markets Wrap
Asian markets are experiencing volatility as AI-driven gains in chipmakers clash with broader regional retreats.
AMD Stock Rises as Goldman Sees Big Earnings Coming
AMD stock is climbing following optimistic earnings projections from Goldman Sachs and strong performance in the first half of 2026.
Blockbuster AI Deal Shows Why Honeywell Had to Break Up
Honeywell spin-off Solstice is targeting the AI supply chain with a massive acquisition of Element Solutions.